SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-26
DOI
10.3389/fonc.2021.682762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High expression of hypoxia inducible factor 1α related with acquired resistant to EGFR tyrosine kinase inhibitors in NSCLC
- (2021) Qian Jin et al. Scientific Reports
- Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models
- (2021) Iwona Ziółkowska-Suchanek Cells
- Metabolism of Innate Immune Cells in Cancer
- (2021) Ronan Talty et al. Cancers
- Hypoxia-Activated Prodrug Enabling Synchronous Chemotherapy and HIF-1α Downregulation for Tumor Treatment
- (2021) Xiangjie Luo et al. BIOCONJUGATE CHEMISTRY
- Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling
- (2021) Wenxia Jiang et al. Balkan Medical Journal
- Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small‐cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)
- (2020) Hongjing Zang et al. CANCER
- Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
- (2020) Pearl Lee et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
- (2020) Chung-Yu Huang et al. Cancers
- Role of Sirtuins in Tumor Angiogenesis
- (2020) Lincy Edatt et al. Frontiers in Oncology
- Mechanisms of resistance to pemetrexed in non-small cell lung cancer
- (2020) Jiaqi Liang et al. Translational Lung Cancer Research
- Senescent stromal cells promote cancer resistance through SIRT1 loss-potentiated overproduction of small extracellular vesicles
- (2020) Liu Han et al. CANCER RESEARCH
- Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
- (2020) Vivek Singh et al. INFLAMMATION
- Mitochondria Targeting as an Effective Strategy for Cancer Therapy
- (2020) Poorva Ghosh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondria participate in chemoresistance to cisplatin in human ovarian cancer cells
- (2020) Luca X Zampieri et al. MOLECULAR CANCER RESEARCH
- Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cells
- (2020) Zuhal Eroglu et al. Molecular Medicine Reports
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma
- (2020) Shunbin Shi et al. PPAR Research
- Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
- (2020) Johannes F. Fahrmann et al. Frontiers in Oncology
- Different mechanisms of cisplatin resistance development in human lung cancer cells
- (2020) Keisuke Okamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
- (2020) Fuming Li et al. DEVELOPMENTAL CELL
- Hypoxia-induced NAD+ interventions promote tumor survival and metastasis by regulating mitochondrial dynamics
- (2020) Xiaoyu Yan et al. LIFE SCIENCES
- Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer
- (2020) Surya K. Tripathi et al. MEDICINAL RESEARCH REVIEWS
- Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
- (2020) Swastika Maity et al. Pharmacological Reports
- Intercellular Mitochondrial Transfer in the Tumor Microenvironment
- (2020) Hana Sahinbegovic et al. Cancers
- Hypoxia-induced epithelial to mesenchymal transition in cancer
- (2020) Robert Y. Hapke et al. CANCER LETTERS
- Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway
- (2020) Yuhong Lu et al. CANCER RESEARCH
- Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
- (2020) Li Yan et al. MEDICINE
- Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook
- (2020) Lena Horvath et al. Molecular Cancer
- The next tier of EGFR resistance mutations in lung cancer
- (2020) Hannah L. Tumbrink et al. ONCOGENE
- p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer
- (2020) Xinyue Deng et al. Frontiers in Oncology
- The Resistance Mechanisms of Lung Cancer Immunotherapy
- (2020) Fen Wang et al. Frontiers in Oncology
- Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
- (2020) Hirva Mamdani et al. Frontiers in Cell and Developmental Biology
- Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype
- (2020) Monique B. Nilsson et al. Journal of Thoracic Oncology
- Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
- (2020) Laura Boyero et al. Cancers
- Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
- (2020) Dimas Carolina Belisario et al. Cells
- Sirtuins' control of autophagy and mitophagy in cancer
- (2020) Michele Aventaggiato et al. PHARMACOLOGY & THERAPEUTICS
- Blocking OLFM4/HIF-1α axis alleviates hypoxia-induced invasion, epithelial-mesenchymal transition, and chemotherapy resistance in non-small-cell lung cancer
- (2019) Xian-Zheng Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
- (2019) Neelum Aziz Yousafzai et al. Cell Death & Disease
- The role of different SIRT1-mediated signaling pathways in toxic injury
- (2019) Zhihua Ren et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression
- (2019) Mohamed E.M. Saeed et al. PHYTOMEDICINE
- The Mitochondrion as an Emerging Therapeutic Target in Cancer
- (2019) Katherine G. Roth et al. TRENDS IN MOLECULAR MEDICINE
- Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
- (2019) Santoni-Rugiu et al. Cancers
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- RBM38 induces SIRT1 expression during hypoxia in non-small cell lung cancer cells by suppressing MIR34A expression
- (2019) Qing-yan Lin et al. BIOTECHNOLOGY LETTERS
- Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
- (2019) Alexandru Andrei Tirpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
- (2019) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
- (2019) Ali F. Abdel-Wahab et al. PHARMACOLOGICAL RESEARCH
- Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma
- (2019) Jiangtao Sun et al. NEOPLASIA
- SIRT1 and HIF1α signaling in metabolism and immune responses
- (2018) Qing Yu et al. CANCER LETTERS
- Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
- (2018) Chiara Tomasello et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
- (2018) Saghar Yousefnia et al. GENE
- Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer
- (2018) Chih-Chao Hsu et al. GENES & DEVELOPMENT
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- (2018) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
- (2018) Yuhong Lu et al. MOLECULAR CANCER RESEARCH
- The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer
- (2018) Grégory Noël et al. SEMINARS IN CANCER BIOLOGY
- Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
- (2018) David Bargiela et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor
- (2018) Seong-Hoon Yun et al. PPAR Research
- Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible facor‑1α in non‑small cell lung cancer A549 cells
- (2018) Qiang Guo et al. Oncology Letters
- Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway
- (2018) Jiawen You et al. MEDICAL SCIENCE MONITOR
- PGC1α: Friend or Foe in Cancer?
- (2018) Francesca Mastropasqua et al. Genes
- Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
- (2018) Christophe Deben et al. Cancers
- Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
- (2018) Maria Apicella et al. Cell Metabolism
- Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer
- (2018) Jian Gong et al. Cancer Management and Research
- Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
- (2018) Daniel Heudobler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The roles of sirtuins family in cell metabolism during tumor development
- (2018) Shunqin Zhu et al. SEMINARS IN CANCER BIOLOGY
- PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway
- (2017) Jie Ni et al. EXPERIMENTAL CELL RESEARCH
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Chemotherapeutics-resistance “arms” race: An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancer
- (2017) Pankaj Kumar Singh et al. LIFE SCIENCES
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondrial function in hypoxic ischemic injury and influence of aging
- (2017) P. Benson Ham et al. PROGRESS IN NEUROBIOLOGY
- SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells
- (2017) David Hamisi Mvunta et al. Translational Oncology
- YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
- (2017) Wenyi Mi et al. Nature Communications
- Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis
- (2017) Yifei Chen et al. Oncotarget
- Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
- (2017) Qian Gou et al. Oncotarget
- PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
- (2017) Alberto Cruz-Bermúdez et al. Scientific Reports
- Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells
- (2017) Lan-Feng Dong et al. eLife
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression
- (2017) Jie Qin et al. Scientific Reports
- Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia
- (2016) Yongqiang Chen et al. Autophagy
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sirt1: Role Under the Condition of Ischemia/Hypoxia
- (2016) Xiaofei Meng et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Who watches the watchmen? Regulation of the expression and activity of sirtuins
- (2016) Marcin Buler et al. FASEB JOURNAL
- Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis
- (2016) Yujia Yuan et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Review on EGFR Inhibitors: Critical Updates
- (2016) Davinder Singh et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Low oxygen level increases proliferation and metabolic changes in bovine granulosa cells
- (2016) Shogo Shiratsuki et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Role of PGC1 in Cancer Metabolism and its Therapeutic Implications
- (2016) Z. Tan et al. MOLECULAR CANCER THERAPEUTICS
- PPARγas a Novel Therapeutic Target in Lung Cancer
- (2016) Aravind T. Reddy et al. PPAR Research
- SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis
- (2016) Yuming Li et al. Oncotarget
- Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer
- (2016) Mingxing Wang et al. Oncotarget
- Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
- (2016) Norikazu Matsuo et al. Scientific Reports
- SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct interactions during hypoxia
- (2015) Hyun-Yoo Joo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sirtuin regulation in aging and injury
- (2015) Ninu Poulose et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib
- (2015) Shinsuke Hashida et al. CANCER SCIENCE
- EGFR/MDM2 signaling promotes NF-κB activation via PPARγ degradation
- (2015) Ying Xu et al. CARCINOGENESIS
- SIRT1/PGC1 -Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer
- (2015) T. T. Vellinga et al. CLINICAL CANCER RESEARCH
- Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment
- (2015) Susan E. Scanlon et al. DNA REPAIR
- Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology
- (2015) Xi Chen et al. IMMUNOLOGY
- Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
- (2015) Glenn Simmons et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC)
- (2015) Ting Shuang et al. MEDICAL ONCOLOGY
- Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis
- (2015) Jihye Kim et al. PLoS One
- Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer
- (2015) Nils D. Arvold et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells
- (2015) Hui-Mei Wu et al. Scientific Reports
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
- (2015) Ivana Grbesa et al. PLoS One
- Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
- (2015) Raju C. Reddy et al. NEOPLASIA
- RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis
- (2014) W Chen et al. CELL DEATH AND DIFFERENTIATION
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteomic signatures associated with p53 mutational status in lung adenocarcinoma
- (2014) Ayumu Taguchi et al. PROTEOMICS
- Sirt1 is a tumor promoter in lung adenocarcinoma
- (2014) XUE CHEN et al. Oncology Letters
- High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
- (2014) Xiaojing Chen et al. Scientific Reports
- Hypoxia induces peroxisome proliferator-activated receptor γ expression via HIF-1-dependent mechanisms in HepG2 cell line
- (2013) Ying-Ze Zhao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
- (2013) D. H. Shin et al. CANCER RESEARCH
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging
- (2013) Ana P. Gomes et al. CELL
- Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance
- (2013) Jennifer Pasquier et al. Journal of Translational Medicine
- SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
- (2013) B Mao et al. ONCOGENE
- Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells
- (2013) Barbara Del Bello et al. PLoS One
- SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
- (2013) Tao Zhang et al. PLoS One
- The emerging and diverse roles of sirtuins in cancer: a clinical perspective
- (2013) WenYong Chen et al. OncoTargets and Therapy
- Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
- (2012) Jean-Philippe Cosse et al. Anti-Cancer Agents in Medicinal Chemistry
- 4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity
- (2012) NJ Lee et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors
- (2012) Kunihiko Minakata et al. CANCER SCIENCE
- Mechanism of cisplatin resistance in human urothelial carcinoma cells
- (2012) Hui-Min Yu et al. FOOD AND CHEMICAL TOXICOLOGY
- Exogenous NAD+supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway
- (2012) Ling Liu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Inhibitory effect of PPARγ on NR0B1 in tumorigenesis of lung adenocarcinoma
- (2012) YOSHIYUKI SUSAKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression of EGFR Under Tumor Hypoxia: Identification of a Subpopulation of Tumor Cells Responsible for Aggressiveness and Treatment Resistance
- (2012) Ilse J. Hoogsteen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Expression of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) in Human Non-small Cell Lung Carcinoma: Correlation with Clinicopathological Parameters, Proliferation and Apoptosis Related Molecules and Patients’ Survival
- (2012) Costantinos Giaginis et al. PATHOLOGY & ONCOLOGY RESEARCH
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
- (2011) Christoph Wohlkoenig et al. CANCER LETTERS
- Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I Activity
- (2011) Daniel Tello et al. Cell Metabolism
- FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
- (2011) Kim Steen Jensen et al. EMBO JOURNAL
- Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner
- (2011) Rui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapy
- (2011) Ajaya Kumar Reka et al. LUNG CANCER
- PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling
- (2011) Aleck W.E. Jones et al. MITOCHONDRION
- PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
- (2011) Nirmalya Sen et al. MOLECULAR CELL
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin resistance: Preclinical findings and clinical implications
- (2010) Beate Köberle et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone
- (2010) Jung Ok Ban et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) and Sirtuin 1 (SIRT1) Reside in Mitochondria
- (2010) Katia Aquilano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells
- (2010) L. Harhaji-Trajkovic et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescence
- (2010) Limin Han et al. NUCLEIC ACIDS RESEARCH
- SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
- (2010) Cian J. Lynch et al. PLoS One
- PPARγ inhibits NF-κB-dependent transcriptional activation in skeletal muscle
- (2009) A. H. V. Remels et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now